Mural Oncology

Mural Oncology, a spin out from Alkermes, is developing cytokine-based immunotherapies for the treatment of cancer.

Jefferies Healthcare Conference London 2024
Biotech

The JPM pregame: Jam-packed Jefferies conference makes its mark

Delegates told Fierce that the mix of pharma and finance attendees is helping boost the popularity of the expanding London conference.
James Waldron Nov 19, 2024 11:00am
Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am
An artists rendering of cytokines being released from immune cells

AACR: Mural debuts data for potential pipeline additions

Apr 10, 2024 11:16am